Lyophilized Powder For Reconstitution Generics Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for reconstitution
Available Strengths: 1 mg/vial, 2 mg/vial, 5 mg/vial
Reference Brands: Ultiva® (US & EU)
Category:
Anaesthetics
Remifentanil Hydrochloride is a fast-acting opioid analgesic used in general anesthesia, available in 1 mg, 2 mg, and 5 mg vials. Approved in the US and EU under Ultiva® and generics.
Lyophilized powder for reconstitution Generics is available in Lyophilized powder for reconstitution
and strengths such as 1 mg/vial, 2 mg/vial, 5 mg/vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lyophilized powder for reconstitution Generics is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lyophilized powder for reconstitution Generics can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Remifentanil Hydrochloride is a potent, ultra-short-acting opioid analgesic used in general anesthesia for precise, moment-to-moment pain control during surgical procedures. Supplied as a lyophilized powder for IV reconstitution, it is available in 1 mg, 2 mg, and 5 mg vials. With rapid onset and metabolism via non-specific plasma esterases, it offers fast recovery with minimal accumulation—ideal for both short and long procedures. Approved in the US (FDA) and EU (EMA) under brands like Ultiva® and various generics, it is a key product for pharma B2B distribution, hospital tenders, and anesthetic portfolios in regulated markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing